Skip to main content

Table 2 Dose constraints for organ at risk (OAR)

From: A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer

OAR

Dose constraints for each HBT

Dose constraints for combination of EBRT and all HBTs (EQD2)

Rectum D2cc

<6.15 Gy

< 75 Gy

Bladder D2cc

< 7.30 Gy

< 90 Gy

Sigmoid D2cc

< 6.15 Gy

< 75 Gy

  1. D2cc: most exposed 2 cc of tissue
  2. EQD2: equivalent dose in 2 Gy fractions
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us